John Tilton, Chief Commercial Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 30,000 shares at $29.10 ($878K) on 2017-11-01, disclosed to the SEC on 2017-11-02.
Open-market sale of $878k BHVN by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.10 | 21,347 | $621K | 70.8% |
| 2 | $29.63 | 8,653 | $256K | 29.2% |
| Total | $29.25 avg | 30,000 | $878K | 100% |
| Filing → |
| BHVN | SELL | 2019-01-14 | $396K | — | Filing → |